| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 185.2 | 193.8 | 185.9 |
| Other income | 0.6 | 3.1 | 1.0 |
| Total income | 185.8 | 196.9 | 186.9 |
| Profit before exceptional items & tax | 15.0 | 16.9 | 9.9 |
| Profit before tax | 15.0 | 16.9 | 9.9 |
| Net profit | 11.2 | 11.4 | 7.6 |
| Operating margin | 8.1% | 8.6% | 5.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +47.40% |
|---|---|
| Net profit, quarter on quarter | -1.80% |
| Revenue, year on year | -0.40% |
| Operating profit, year on year | +61.80% |
| Operating profit, quarter on quarter | +4.30% |
NSE results filing, NSE: ANUHPHR. Figures extracted from the filing.
Anuh Pharma Ltd: key numbers
- Share price
- ₹87.31
- Market cap
- ₹875.1 Cr
- Revenue (annual)
- ₹771.7 Cr
- Net profit (annual)
- ₹41.05 Cr
- P/E (TTM)
- 19.8×Sector 48.7×
- Promoter holding
- 71.80%+0.00% QoQ
- FII holding
- 0.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anuh Pharma Ltd
All →Anuh Pharma Promoter Reclassification
Anuh Pharma's promoter group member Nina Vijay Shah withdrew her request to reclassify to the public category. She remains in the promoter group.
Anuh Pharma Board Meeting Date
Anuh Pharma's board meets on 30 October 2026 to approve Q1/H1 FY27 results. Trading window closed for insiders until 1 November 2026.
Anuh Pharma Acquisition Worth ₹72.9 Cr
Anuh Pharma signed an Asset Transfer Agreement to acquire a manufacturing facility from Vanquest Pharma for ₹72.90 Crore, increasing its production capacity by 525 MTPA.
- Value
- ₹72.90 Cr
- manufacturing capacity
- 525.0 MTPA
Anuh Pharma Debt & Borrowing: ₹75 Cr
Anuh Pharma Ltd board approved a loan of ₹75 Crore to finance manufacturing asset investments for expanding production capacity.
- Value
- ₹75.00 Cr
Anuh Pharma Other Announcement
Anuh Pharma Ltd filed the quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as issued by its RTA.
Anuh Pharma Legal & Regulatory
Anuh Pharma disclosed a Rs. 9,93,206 tax demand under Section 156, Income Tax Act, for AY 2018-19. The company plans to appeal before the CIT.
- Value
- ₹0.10 Cr